Literature DB >> 17672042

Human papillomavirus infection and disease in the HIV+ individual.

Jennifer E Cameron1, Michael E Hagensee.   

Abstract

HPV infection of both the genital tract and oral cavity of HIV+ men and women is increased. HPV-related pathology is also increased in the HIV+ individuals, usually with further increases seen for those HIV+ individuals with lower CD4 cell counts. Fortunately, the rates of cervical cancer and anal cancer are relatively low and not related to CD4 cell count. Treatment of the HIV+ individual with HPV-related disease is challenging and requires close long-term follow-up to prevent recurrent disease. The mechanism of how HPV and HIV interact is still not known but is more likely to be linked to immune suppression rather than a direct interaction between viruses. The newly developed HPV vaccines will likely have a significant impact on HPV-related disease in immunocompetent individuals. It remains to be seen what impact these vaccine will have on the immune depressed.

Entities:  

Mesh:

Year:  2007        PMID: 17672042     DOI: 10.1007/978-0-387-46816-7_7

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  9 in total

Review 1.  [HPV-associated carcinomas of the female genital tract. Molecular mechanisms of development].

Authors:  M Reuschenbach; S Vinokurova; M von Knebel Doeberitz
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

2.  Prevalence of Anal HPV Infection Among HIV-Positive Men Who Have Sex With Men in India.

Authors:  Alexandra L Hernandez; Rajiv Karthik; Murugesan Sivasubramanian; Anantharam Raghavendran; Manu Gnanamony; Shelly Lensing; Jeannette Y Lee; Rajesh Kannangai; Priya Abraham; Dilip Mathai; Joel M Palefsky
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

3.  A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa.

Authors:  Hilary K Whitham; Stephen E Hawes; Haitao Chu; J Michael Oakes; Alan R Lifson; Nancy B Kiviat; Papa Salif Sow; Geoffrey S Gottlieb; Selly Ba; Marie P Sy; Shalini L Kulasingam
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-05-17       Impact factor: 4.254

Review 4.  Optimal timing of routine vaccination in HIV-infected persons.

Authors:  Heidi M Crane; Shireesha Dhanireddy; H Nina Kim; Christian Ramers; Timothy H Dellit; Mari M Kitahata; Robert D Harrington
Journal:  Curr HIV/AIDS Rep       Date:  2009-05       Impact factor: 5.071

Review 5.  The role of infectious agents in the etiology of ocular adnexal neoplasia.

Authors:  Varun Verma; Defen Shen; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 6.048

6.  Risk of human papillomavirus-associated cancers among persons with AIDS.

Authors:  Anil K Chaturvedi; Margaret M Madeleine; Robert J Biggar; Eric A Engels
Journal:  J Natl Cancer Inst       Date:  2009-07-31       Impact factor: 13.506

Review 7.  Dermatologic manifestations of HPV in HIV-infected individuals.

Authors:  Rachel H Gormley; Carrie L Kovarik
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

8.  Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination.

Authors:  Bipin N Savani; Pamela Stratton; Aarthi Shenoy; Eleftheria Kozanas; Stacey Goodman; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

9.  Prevalence of oral human papillomavirus infection among Indian HIV-positive men who have sex with men: a cross-sectional study.

Authors:  Alexandra L Hernandez; Rajiv Karthik; Murugesan Sivasubramanian; Anantharam Raghavendran; Shelly Lensing; Jeannette Y Lee; Priya Abraham; Dilip Mathai; Joel M Palefsky
Journal:  BMC Infect Dis       Date:  2021-07-12       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.